General Notices

• Notice to Include Additional Application Due Dates for NIDCR Dual Degree Dentist Scientist Pathway to Independence Award (K99/R00)
  (NOT-DE-22-007)
  National Institute of Dental and Craniofacial Research
  

• Notice of Early Termination of NOT-HG-22-006, Notice of Participation of Additional NIH Institutes and Centers in PAR-20-153: Science Education Partnership Awards (SEPA) (R25-Clinical Trial Not Allowed)
  (NOT-HG-22-016)
  National Human Genome Research Institute
  

• Notice of Participation of Additional NIH Institutes and Centers in PAR-20-153: Science Education Partnership Awards (SEPA) (R25-Clinical Trial Not Allowed)
  (NOT-HG-22-017)
  National Human Genome Research Institute
  National Center for Advancing Translational Sciences
  National Center for Complementary and Integrative Health
  National Eye Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Allergy and Infectious Diseases
  National Institute of Biomedical Imaging and Bioengineering
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Mental Health
  National Institute on Minority Health and Health Disparities
  National Institute of Neurological Disorders and Stroke
  National Institute of Nursing Research
  Office of Research on Women's Health
  

• Notice of Extension of NOT-HL-20-761 "Notice of Special Interest (NOSI): Pulmonary Complications of Hematopoietic Stem Cell Transplantation in Childhood"
  (NOT-HL-22-020)
  National Heart, Lung, and Blood Institute
  

• Modifications to the NIMH Special Council Review Procedures
  (NOT-MH-22-190)
  National Institute of Mental Health
  

• Request for Information (RFI): Identification of a Set of Determinants for Whole Person Health
  (NOT-AT-22-019)
  National Center for Complementary and Integrative Health
  

• Request for Information (RFI): Seeking Input for the National Cancer Institute (NCI) on Advancing Research in Immuno-oncology, Immunoprevention, and/or Immunotherapy.
  (NOT-CA-22-072)
  National Cancer Institute
  

Notice of Changes to Funding Opportunities

• Notice of Correction to RFA-CA-22-013, "PDX Data Commons and Coordinating Center (PDCCC) for the PDX Development and Trial Centers Research Network (PDXNet) (U24 Clinical Trial Not Allowed)"
  (NOT-CA-22-073)
  National Cancer Institute
  

• Notice of Expiration of NOT-HL-19-677 "Notice of Special Interest SEARCH: Stimulating ExplorAtory Research on HIV/AIDS Contribution to Heart, Lung, Blood and Sleep Comorbidities (R01 - Clinical Trial Not Allowed)"
  (NOT-HL-22-021)
  National Heart, Lung, and Blood Institute
  

• Notice of Participation of National Institute on Minority Health and Health Disparities (NIMHD) in PAR-22-137 & PAR-22-138, "Accelerating the Pace of Child Health Research Using Existing Data from the Adolescent Brain Cognitive Development (ABCD) Study"
  (NOT-MD-22-014)
  National Institute on Minority Health and Health Disparities
  

• Notice of Early Expiration of NOT-MH-22-085 Notice of Special Interest (NOSI): Administrative Supplements for NIMH Grants to Inform the Assessment of Suicide Thoughts and Behaviors among Children and Preteens
  (NOT-MH-22-196)
  National Institute of Mental Health
  

Notices of Intent to Publish

• Notice of Intent to Publish a Funding Opportunity Announcement for Cancer Adoptive Cellular Therapy Network (Can-ACT) for Adult Cancers (UG3/UH3 Clinical Trial Required)
  (NOT-CA-22-074)
  National Cancer Institute
  

• Notice of Intent to Publish a Funding Opportunity Announcement for Cancer Adoptive Cellular Therapy Network (Can-ACT) for Pediatric Cancers (UG3/UH3 Clinical Trial Required)
  (NOT-CA-22-075)
  National Cancer Institute
  

• Notice of Intent to Publish a Funding Opportunity Announcement for Cancer Adoptive Cellular Therapy Network (Can-ACT) Coordinating Center (U24 Clinical Trial Not Allowed)
  (NOT-CA-22-076)
  National Cancer Institute
  

• Notice of Intent to Publish a Funding Opportunity Announcement for Research to Understand and Address the Survivorship Needs of Individuals Living with Advanced Cancer (R01 Clinical Trial Optional)
  (NOT-CA-22-077)
  National Cancer Institute
  

• Notice of Intent to Publish a Funding Opportunity Announcement for Precision Approaches in Radiation Synthetic combinations (PAIRS, R01 Clinical Trial Optional)
  (NOT-CA-22-078)
  National Cancer Institute
  

• Notice of Intent to Publish a Funding Opportunity Announcement for Precision Approaches in Radiation Synthetic combinations (PAIRS, R21 Clinical Trial Optional)
  (NOT-CA-22-079)
  National Cancer Institute
  

• Notice of Intent to Publish a Funding Opportunity Announcement for Novel Assays to Address Translational Gaps in Treatment Development (UG3/UH3 Clinical Trial Optional)
  (NOT-MH-22-210)
  National Institute of Mental Health
  

• Notice of Intent to Publish a Funding Opportunity Announcement for Building in vivo Preclinical Assays of Circuit Engagement for Application in Therapeutic Development (R01 Clinical Trial Not Allowed)
  (NOT-MH-22-211)
  National Institute of Mental Health
  

Notices of Special Interest

• Notice of Special Interest (NOSI): Administrative Supplements for Examining Patterns of Tobacco and Cannabis Use
  (NOT-CA-22-070)
  National Cancer Institute
  

• Notice of Special Interest (NOSI): Administrative Supplements for Research on Womens Health in the IDeA States
  (NOT-GM-22-005)
  National Institute of General Medical Sciences
  National Center for Complementary and Integrative Health
  National Cancer Institute
  National Eye Institute
  National Heart, Lung, and Blood Institute
  National Institute on Aging
  National Institute of Allergy and Infectious Diseases
  National Institute of Biomedical Imaging and Bioengineering
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute of Dental and Craniofacial Research
  National Institute of Environmental Health Sciences
  National Institute of Nursing Research
  Office of Disease Prevention
  Office of Research on Women's Health
  

• Notice of Special Interest (NOSI): Administrative Supplements for NIMH Grants to Inform the Assessment of Suicide Thoughts and Behaviors among Children and Preteens
  (NOT-MH-22-195)
  National Institute of Mental Health
  National Institute on Drug Abuse
  National Institute on Minority Health and Health Disparities
  

Funding Opportunities

• National Institute of General Medical Sciences (NIGMS) Bridges to the Baccalaureate Research Training Program (T34)
  (PAR-22-125)
  National Institute of General Medical Sciences
  Application Receipt Date(s): September 25, 2024
  
  

• Research Projects in Physical Sciences-Oncology (U01 Clinical Trial Optional)
  (PAR-22-147)
  National Cancer Institute
  Application Receipt Date(s): Multiple dates, see announcement.
  
  

• Laboratories to Optimize Digital Health (R01 Clinical Trial Required)
  (PAR-22-154)
  National Institute of Mental Health
  Application Receipt Date(s): January 05, 2023
  
  

• Alcohol Health Services Research (R01 Clinical Trial Optional)
  (PAR-22-156)
  National Institute on Alcohol Abuse and Alcoholism
  Office of Research on Women's Health
  Application Receipt Date(s): May 07, 2023
  
  

• Alcohol Health Services Research (R34 Clinical Trial Optional)
  (PAR-22-157)
  National Institute on Alcohol Abuse and Alcoholism
  Application Receipt Date(s): May 07, 2023
  
  

• Alcohol Treatment and Recovery Research (R01 Clinical Trial Required)
  (PAR-22-158)
  National Institute on Alcohol Abuse and Alcoholism
  Application Receipt Date(s): May 07, 2023
  
  

• Alcohol Treatment and Recovery Research (R34 Clinical Trial Required)
  (PAR-22-159)
  National Institute on Alcohol Abuse and Alcoholism
  Application Receipt Date(s): May 07, 2023
  
  

• Cancer Epidemiology Cohorts: Building the Next Generation of Research Cohorts (U01 Clinical Trial Not Allowed)
  (PAR-22-161)
  National Cancer Institute
  Application Receipt Date(s): February 28, 2025
  
  

• Development and Optimization of Next-Generation Immunological Assays to Support Influenza Clinical Studies and Trials (UH2/UH3 Clinical Trial Not Allowed)
  (RFA-AI-22-020)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): July 01, 2022
  
  

• Partnerships for the Development of Novel Therapeutics to Combat Select Antibiotic Resistant Bacteria and Fungi (R01 Clinical Trial Not Allowed)
  (RFA-AI-22-028)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): July 29, 2022
  
  

• Pediatric Immunotherapy Network (PIN) (U01 Clinical Trial Optional)
  (RFA-CA-22-016)
  National Cancer Institute
  Application Receipt Date(s): September 27, 2022
  
  

• Cancer Prevention, Detection, Diagnosis, and Treatment Technologies for Global Health (U01 Clinical Trial Optional)
  (RFA-CA-22-020)
  National Cancer Institute
  Office of Research on Women's Health
  Application Receipt Date(s): June 17, 2022
  
  

• SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies Toward Commercialization (R44 Clinical Trial Optional)
  (RFA-CA-22-025)
  National Cancer Institute
  Application Receipt Date(s): August 6, 2021
  
  

• Increasing Immediate Engagement and Retention in HIV Treatment with Substance Users (R01- Clinical Trials Required)
  (RFA-DA-23-002)
  National Institute on Drug Abuse
  Application Receipt Date(s): August 11, 2022
  
  

• NIDCD Research Opportunities for New Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional)
  (RFA-DC-23-001)
  National Institute on Deafness and Other Communication Disorders
  Application Receipt Date(s): August 04, 2023
  
  

• A Community Research Resource: Characterization of the Resident Ocular Microbiome. (U24 Clinical Trial Not Allowed)
  (RFA-EY-22-001)
  National Eye Institute
  Application Receipt Date(s): July 06, 2022
  
  

• Reducing Racial and Ethnic Healthcare Disparities in Chronic Conditions by Dissemination and Implementation of Patient Centered Outcomes Research (PCOR) Evidence (R18)
  (RFA-HS-22-001)
  Agency for Healthcare Research and Quality
  Application Receipt Date(s): June 17, 2022
  
  

• Diagnostic Centers of Excellence: Partnerships to Improve Diagnostic Safety and Quality (R18)
  (RFA-HS-22-008)
  Agency for Healthcare Research and Quality
  Application Receipt Date(s): June 09, 2022
  
  

• Limited Competition: Research Centers in Minority Institutions (RCMI) Clinical Research Network for Health Equity (UG3/UH3 - Clinical Trial Optional)
  (RFA-MD-22-006)
  National Institute on Minority Health and Health Disparities
  Application Receipt Date(s): May 31, 2022
  
  

• INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Clinical Trial Readiness (R21 Clinical Trial Not Allowed)
  (RFA-OD-22-007)
  Office of the Director, NIH
  National Cancer Institute
  National Eye Institute
  National Heart, Lung, and Blood Institute
  National Institute on Aging
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Deafness and Other Communication Disorders
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): July 01, 2024
  
  

• Small Research Grants for Analysis, Curation, and/or Sharing of Down syndrome-related Research Data for the INCLUDE Project (R03 Clinical Trial Not Allowed)
  (RFA-OD-22-008)
  Office of the Director, NIH
  National Cancer Institute
  National Eye Institute
  National Human Genome Research Institute
  National Heart, Lung, and Blood Institute
  National Institute on Aging
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Deafness and Other Communication Disorders
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): Multiple dates, see announcement.
  
  

• Transformative Research Award for the INCLUDE (Investigation of Co-occurring Conditions across the Lifespan to Understand Down syndrome) Project (R01 Clinical Trial Not Allowed)
  (RFA-OD-22-009)
  Office of the Director, NIH
  National Cancer Institute
  National Eye Institute
  National Human Genome Research Institute
  National Heart, Lung, and Blood Institute
  National Institute on Aging
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Mental Health
  National Institute of Neurological Disorders and Stroke
  Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
  Application Receipt Date(s): July 01, 2024
  
  

• Clinical Trials Development for Co-Occurring Conditions in Individuals with Down syndrome: Phased Awards for INCLUDE (R61/R33 Clinical Trial Required)
  (RFA-OD-22-010)
  Office of the Director, NIH
  National Cancer Institute
  National Eye Institute
  National Heart, Lung, and Blood Institute
  National Institute on Aging
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Deafness and Other Communication Disorders
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): July 01, 2024
  
  

• Emergency Award: Rapid Acceleration of Diagnostics Tribal Data Repository (RADx TDR) (U24 Clinical Trial Not Allowed)
  (RFA-OD-22-011)
  Office of the Director, NIH
  National Institute on Aging
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute of Environmental Health Sciences
  National Institute of General Medical Sciences
  National Institute of Mental Health
  National Institute on Minority Health and Health Disparities
  National Institute of Neurological Disorders and Stroke
  National Library of Medicine
  Application Receipt Date(s): May 31, 2022
  
  

• NIH Directors New Innovator Award Program (DP2 Clinical Trial Optional)
  (RFA-RM-22-019)
  Office of Strategic Coordination (Common Fund)
  Application Receipt Date(s): August 19, 2022